Skip to the content

Director, Business Analysis & Insight Jazz Pharmaceuticals

Dennis Engelke

Since joining Jazz Pharmaceuticals in 2015, Dennis has been working in the International Portfolio Planning team responsible for the analysis and monitoring of the current Haematology/Oncology and Sleep Medicine business by providing commercial insights which meaningfully improve brand strategies across the International region. In addition, he is assessing development assets or acquisition targets, contributing towards the final Go/No-Go decision. He is working in close collaboration with the commercial, medical, and business development leadership teams ensuring identification of insights, transfer of best practice and a holistic assessment of new product targets.

Dennis has 12 years of hands-on experience in the innovative and generic pharmaceutical industry and held previously global strategic marketing, business development and business intelligence positions for Specialty Pharmaceuticals at Actelion Pharmaceuticals and Fresenius Kabi.

He holds a Masters degree in Business and Economics from the Universities of Hamburg (Germany) and Uppsala (Sweden).

EphMRA 2020 - Antwerp - June 23-25 - put the dates in your diary!

The submission deadline for speakers who are interested in speaking next year has now passed and our Programme Committee are busy evaluating the many submissions that we received.  We are actively looking for outstanding speakers for plenary sessions, so do get in touch if you know of or have seen speakers who would add value to our conference. Contact Caroline Snowdon - [email protected] or Bernadette Rogers - [email protected] - we'd love to hear from you!